Background Respiratory syncytial virus (RSV) causes substantial winter pressure on adult services. In the UK, RSV vaccination ...

Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

The Family Health Care Institute (one of the King Hussein Foundation institutes) provides the reader today, Wednesday, with ...

The Vaccine Integrity Project, in collaboration with the American Medical Association (AMA), has announced the kickoff of a ...

The NHS is expanding free RSV vaccination to over-80s and care home residents, aiming to protect those most at risk of severe illness.

The European approval for GSK's depemokimab joins recently announced data on vaccine efficacy and progress on 4-month viral treatments.

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...

Respiratory infections are the leading causes of hospitalizations, ED visits and mortality in children in the United States ...

The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

The federal government updated the U.S. childhood vaccine schedule in January. Find out if the changes impact your child, ...

Among children younger than 2, the preventive effects of nirsevimab against RSV were maintained for up to 12 months after administration.

Acute respiratory infections remain one of the leading causes of hospitalization in children worldwide. Pathogens may interact with one another, altering disease patterns in unpredictable ways. The ...